Treating atopic dermatitis: safety, efficacy, and patient acceptability of a ceramide hyaluronic acid emollient foam.

about

Treating atopic dermatitis: safety, efficacy, and patient acceptability of a ceramide hyaluronic acid emollient foam.

Item

http://www.wikidata.org/entity/Q42126636

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Treating atopic dermatitis: sa ...... yaluronic acid emollient foam.

@en

Treating atopic dermatitis: sa ...... yaluronic acid emollient foam.

@nl

type

Item

label

Treating atopic dermatitis: sa ...... yaluronic acid emollient foam.

@en

Treating atopic dermatitis: sa ...... yaluronic acid emollient foam.

@nl

prefLabel

Treating atopic dermatitis: sa ...... yaluronic acid emollient foam.

@en

Treating atopic dermatitis: sa ...... yaluronic acid emollient foam.

@nl

P1476

Treating atopic dermatitis: sa ...... yaluronic acid emollient foam.

@en

P2093

Adelaide A Hebert

http://www.w3.org/2001/XMLSchema#string

Omar Pacha

http://www.w3.org/2001/XMLSchema#string

P2860

Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data.

Ceramide modulates HERG potassium channel gating by translocation into lipid rafts

Therapeutic moisturizers.

The cornified envelope: a model of cell death in the skin.

Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.

Skin-sensitizing and irritant properties of propylene glycol.

Black box warning for topical calcineurin inhibitors and the death of common sense.

On the effects of topical synthetic pseudoceramides: comparison of possible keratinocyte toxicities provoked by the pseudoceramides, PC104 and BIO391, and natural ceramides

A systematic review of the safety of topical therapies for atopic dermatitis.

The US FDA 'black box' warning for topical calcineurin inhibitors: an ongoing controversy.

P304

39-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/CCID.S23269

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225293926

http://www.w3.org/2001/XMLSchema#string

P698

22690129

http://www.w3.org/2001/XMLSchema#string

P932

3363028

http://www.w3.org/2001/XMLSchema#string